CompletedNot Applicable

HPV Vaccine Intervention for Young Sexual Minority Men

United States1,227 participantsStarted 2019-10-03

Plain-language summary

This phase III trial studies how well the Outsmart HPV intervention works in increasing HPV vaccine initiation and completion among young individuals who report having a history of same-sex partners, being sexually attracted to males, or identify as gay, bisexual, or queer (i.e., sexual minority males). The Outsmart HPV intervention, which is a population-targeted, individually-tailored mHealth intervention that includes vaccine reminders, may increase HPV vaccine initiation and completion among unvaccinated young sexual minority individuals.

Who can participate

Age range18 Years – 25 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Cisgender male * Ages 18-25 * Sexual minority (reports ever having oral or anal sex with a male or being sexually attracted to males; or identifies as gay, bisexual, or queer) * Lives in the United States (US) * Has not received any doses of HPV vaccine * Did not participate in the pilot study * Read English * Able to provide informed consent (inferred by completing the screener survey and consent form)

What they're measuring

Human Papillomavirus (HPV) Vaccine Initiation and Completion

Timeframe: Baseline up to 9 months

Changes in Theoretical Constructs

Timeframe: Baseline up to 9 months

Counts of Human Papillomavirus (HPV) Vaccine Initiation by Participant Characteristics

Timeframe: Baseline up to 9 months

Trial details

NCT IDNCT04032106

SponsorOhio State University Comprehensive Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-03-30

Results submitted2023-01-20

View on ClinicalTrials.gov More Healthy Subject trials